English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/127493
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:

Title

Structural and Kinetic Characterization of Thymidine Kinase from Leishmania major

AuthorsTimm, Jennifer; Bosch-Navarrete, C.; Recio, Eliseo; Nettleship, Joanne E.; Rada, Heather; González-Pacanowska, D.; Wilson, K. S.
Issue DateMay-2015
PublisherPublic Library of Science
CitationPLoS Neglected Tropical Diseases
AbstractLeishmania spp. is a protozoan parasite and the causative agent of leishmaniasis. Thymidine kinase (TK) catalyses the transfer of the γ-phosphate of ATP to 2’-deoxythymidine (dThd) forming thymidine monophosphate (dTMP). L. major Type II TK (LmTK) has been previously shown to be important for infectivity of the parasite and therefore has potential as a drug target for anti-leishmanial therapy. In this study, we determined the enzymatic properties and the 3D structures of holo forms of the enzyme. LmTK efficiently phosphorylates dThd and dUrd and has high structural homology to TKs from other species. However, it significantly differs in its kinetic properties from Trypanosoma brucei TK since purines are not substrates of the enzyme and dNTPs such as dUTP inhibit LmTK. The enzyme had Km and kcat values for dThd of 1.1 μM and 2.62 s-1 and exhibits cooperative binding for ATP. Additionally, we show that the anti-retroviral prodrug zidovudine (3-azido-3-deoxythymidine, AZT) and 5’-modified dUrd can be readily phosphorylated by LmTK. The production of recombinant enzyme at a level suitable for structural studies was achieved by the construction of C-terminal truncated versions of the enzyme and the use of a baculoviral expression system. The structures of the catalytic core of LmTK in complex with dThd, the negative feedback regulator dTTP and the bi-substrate analogue AP5dT, were determined to 2.74, 3.00 and 2.40 Å, respectively, and provide the structural basis for exclusion of purines and dNTP inhibition. The results will aid the process of rational drug design with LmTK as a potential target for anti-leishmanial drugs.
Publisher version (URL)http://journals.plos.org/plosntds/article?id=10.1371/journal.pntd.0003781
URIhttp://hdl.handle.net/10261/127493
DOI10.1371/journal.pntd.0003781
E-ISSN1935-2727
Appears in Collections:(IPBLN) Artículos
Files in This Item:
File Description SizeFormat 
journal.pntd.0003781.pdf3,8 MBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.